Skip to Main Content
American Flag
LABOR DAY SALE

50% off your first year of any Quiver subscription

...

Use Promo Code:

LABOR26
American Flag

Xenon Pharmaceuticals Inc

XENE Real Time Price USD
N/A
N/A
N/A
...
Overview
Financials
Forecast
Insiders
Institutions
Compensation
Government
Ownership
News
Income
Balance Sheet
Cash Flow
Revenue Breakdown

Recent trades of XENE by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard
XENE Stock Insider Trading Activity Follow @QuiverQuant for major insider updates

---

Closing Price
Purchase
Sale
Name
Type
Shares
Price
Shares Held
Date
Reported
XENE Stock Institutional Owners
Investor
Shares
Change in Shares
Market Value
Date
Reported
XENE Derivatives Institutional Owners
Investor
Type
Shares
Change in Shares
Market Value
Date
Reported

Recently reported changes in XENE holdings by institutional investors

Quarterly net insider trading by XENE's directors and management

* Insider trading data parsed from SEC Form 4 filings by Quiver Quantitative. Sign up for the Quiver API for real-time access.

About

Backtest Start Date
CAGR (Total)
Return (30d)
Return (1Y)
  • 1M
  • 3M
  • 6M
  • YTD
  • 1Y
  • 2Y
  • 5Y
  • MAX

About

Backtest Start Date

Key Metrics

Return (1d)

Return (30d)

Return (1Y)

CAGR (Total)

Max Drawdown

Beta

Alpha

Sharpe Ratio

Win Rate

Average Win

Average Loss

Annual Volatility

Annual Std Dev

Information Ratio

Treynor Ratio

Total Trades

Show More
Metrics Definitions

Disclaimer: The performance results shown are based on historical backtesting and are hypothetical in nature. Backtested performance does not represent actual trading and does not account for all market factors that may affect execution, such as liquidity, slippage, and changing market conditions. Past performance is not necessarily indicative of future results. There is no guarantee that any trading strategy will be profitable or avoid losses.

  • Alpha

    Measures a portfolio's risk-adjusted performance against that of its benchmark

    Learn More about Alpha
  • Annual Standard Deviation

    Measures how much the portfolio's total return varies from its mean or average.

    Learn More about Annual Standard Deviation
  • Annual Volatility

    A statistical measure of the dispersion of returns for the portfolio.

    Learn More about Annual Volatility
  • Average Win

    The average return (%) for trades that resulted in a positive return.

  • Average Loss

    The average return (%) for trades that resulted in a negative return.

  • Beta

    A measure of the volatility of the portfolio compared to the market as a whole.

    Learn More about Beta
  • CAGR

    CAGR (Compounded Annual Growth Rate), is the historical annualized rate of return for an investment strategy, throughout the backtest period.

    Learn More about CAGR
  • Information Ratio

    A measurement of portfolio returns beyond the returns of its benchmark compared to the volatility of those returns.

    Learn More about Information Ratio
  • Max Drawdown

    the maximum observed loss from a peak to a trough of a portfolio, before a new peak is attained.

    Learn More about Max Drawdown
  • Sharpe Ratio

    The Sharpe Ratio is a measure of historical risk-adjusted return, which quantifies the amount of return that an investor received per unit of risk.

    Learn More about Sharpe Ratio
  • Total Trades

    The total number of trades made by this strategy.

  • Treynor Ratio

    Attempts to measure how successful an investment is in providing compensation to investors for taking on investment risk.

    Learn More about Treynor Ratio
  • Win Rate

    The percentage of total trades that resulted in a positive return.

Subscribe to Quiver Premium for insider trading alerts

Be the first to see our newest insights and key updates across all datasets.

schema-2

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard

Former government officials who have lobbied for XENE

Quiver Logo

No former government officials on record as having lobbied for XENE

Revolving Door Dashboard

XENE Estimated quarterly lobbying spending

Quiver Logo

No Corporate Lobbying data for this ticker

Corporate Lobbying Dashboard

XENE Revenue by Segment or Geography

By Segment
By Geography
Quiver Logo

No Revenue by Segment data for this ticker

Revenue Breakdown Dashboard
Quiver Logo

No Revenue by Geography data for this ticker

Revenue Breakdown Dashboard
XENE Income Statement
XENE Balance Sheet
XENE Cash Flow
U.S. Patents

New XENE patent grants

  • Patent Title: Synthetic methods for spiro-oxindole compounds Jul. 04, 2017
  • Patent Title: Benzenesulfonamide compounds and their use as therapeutic agents Apr. 25, 2017
  • Patent Title: Pharmaceutical compositions of spiro-oxindole compound for topical administration and their use as therapeutic agents Nov. 29, 2016
  • Patent Title: Asymmetric syntheses for spiro-oxindole compounds useful as therapeutic agents Nov. 08, 2016
  • Patent Title: Biaryl ether sulfonamides and their use as therapeutic agents Nov. 01, 2016
  • Patent Title: Enantiomers of spiro-oxindole compounds and their uses as therapeutic agents Nov. 01, 2016
  • Patent Title: Spiro-oxindole compounds and their use as therapeutic agents Oct. 04, 2016
  • Patent Title: Biaryl ether sulfonamides and their use as therapeutic agents Jun. 14, 2016
  • Patent Title: Methods for identifying analgesic agents Mar. 08, 2016
  • Patent Title: Synthetic methods for spiro-oxindole compounds Feb. 16, 2016
  • Patent Title: N-substituted benzamides and methods of use thereof Feb. 10, 2015
  • Patent Title: N-substituted benzamides and methods of use thereof Jan. 13, 2015
  • Patent Title: Spiro-oxindole compounds and their use as therapeutic agents Dec. 23, 2014
  • Patent Title: Enantiomers of spiro-oxindole compounds and their uses as therapeutic agents Nov. 11, 2014
  • Patent Title: Synthetic methods for spiro-oxindole compounds Jun. 03, 2014
  • Patent Title: Methods and reagents for modulating cholesterol levels May. 06, 2014
  • Patent Title: Aminothiazole derivatives as human stearoyl-coa desaturase inhibitors Sep. 24, 2013
  • Patent Title: Juvenile hemochromatosis gene (hfe2a) cleavage products and uses thereof Aug. 13, 2013
  • Patent Title: Organic compounds Aug. 06, 2013
  • Patent Title: Use of spiro-oxindole compounds as therapeutic agents Jun. 18, 2013
  • Patent Title: Enantiomers of spiro-oxindole compounds and their uses as therapeutic agents May. 28, 2013
  • Patent Title: Synthetic methods for spiro-oxindole compounds May. 21, 2013
  • Patent Title: Spiro-oxindole compounds and their uses as therapeutic agents Apr. 09, 2013
  • Patent Title: Methods for treating pain by inhibition of the scn9a channel Apr. 02, 2013
  • Patent Title: Pyridyl derivatives and their use as therapeutic agents Feb. 26, 2013
  • Patent Title: Spiro-oxindole compounds and their use as therapeutic agents Sep. 11, 2012
  • Patent Title: Juvenile hemochromatosis gene (hfe2a) cleavage products and uses thereof Aug. 28, 2012
  • Patent Title: Pyridyl derivatives and their use as therapeutic agents Apr. 10, 2012
  • Patent Title: Pyridazine derivatives and their use as inhibitors of stearoyl-coa desaturase-1 activity in a mammal Apr. 03, 2012
  • Patent Title: Spiro-oxindole compounds and their uses as therapeutic agents Jan. 31, 2012
  • Patent Title: Spiro-oxindole compounds and their use as therapeutic agents Jan. 24, 2012
  • Patent Title: Juvenile hemochromatosis gene (hfe2a), expression products and uses thereof Dec. 20, 2011
  • Patent Title: Heterocyclic derivatives and their use as stearoyl-coa desaturase inhibitors Dec. 06, 2011
  • Patent Title: Polynucleotide encoding an atp binding cassette transporter 1 (abc1) polypeptide Nov. 29, 2011
  • Patent Title: Piperazine derivatives as stearoyl-coa desaturase inhibitors and their use as therapeutic agents Oct. 04, 2011
  • Patent Title: Substituted pyridazines as stearoyl-coa desaturase inhibitors Sep. 27, 2011
  • Patent Title: Heterocyclic derivatives and their use as mediators of stearoyl-coa desaturase May. 31, 2011
  • Patent Title: Spiro-oxindole compounds and their uses as therapeutic agents May. 03, 2011
  • Patent Title: Heterocyclic derivatives for the treatment of diseases mediated by stearoyl-coa desaturase enzymes Apr. 05, 2011
  • Patent Title: Combination therapy Apr. 05, 2011
  • Patent Title: Juvenile hemochromatosis gene (hfe2a) cleavage products and uses thereof Feb. 22, 2011
  • Patent Title: Pyridazine derivatives for inhibiting human stearoyl-coa-desaturase Nov. 09, 2010
  • Patent Title: Methods and compositions using stearoyl-coa desaturase to identify triglyceride reducing therapeutic agents Oct. 19, 2010
  • Patent Title: Spiroheterocyclic compounds and their uses as therapeutic agents Sep. 21, 2010
  • Patent Title: Methods and reagents for modulating cholesterol levels Aug. 31, 2010
  • Patent Title: Heterocyclic derivatives and their use as therapeutic agents Aug. 17, 2010
  • Patent Title: Heterocyclic derivatives and their use as stearoyl-coa desaturase inhibitors Aug. 03, 2010
  • Patent Title: Pyridyl derivatives and their use as therapeutic agents Jul. 27, 2010
  • Patent Title: Pyridazine derivatives and their use as therapeutic agents Jul. 20, 2010
  • Patent Title: Pyridazine derivatives and their use as therapeutic agents Jul. 13, 2010
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard
Government Contracts

Estimated quarterly amount awarded to XENE from public contracts

Quiver Logo

No recent Government Contracts for this ticker

Government Contracts Dashboard
XENE News

Recent insights relating to XENE

CNBC Recommendations

Recent picks made for XENE stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in XENE

XENE Analyst Ratings

XENE Stock Forecasts
...

  • ... Highest Price Target
  • ... Median Price Target
  • ... Lowest Price Target
XENE Analyst Forecasts
Analyst
Firm
Current
Previous
Date
Frequently Asked Questions
  • Is $XENE stock a Buy, Sell, or Hold?

  • What is the price target for $XENE stock?

* Analyst consensus is not financial advice. Please see our data disclaimers .

XENE Top Shareholders
Shareholder
Shares Held
XENE Options Owners
Shareholder
Security
Underlying Shares
Frequently Asked Questions
  • Who owns $XENE stock?

  • Who owns the most shares of $XENE stock?

  • What funds own $XENE stock?

* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.

XENE Stock Smart Score

The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.

The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?

Sign Up to view XENE Smart Score

Score Breakdown
Bull Case vs Bear Case

See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.

Example:

Bulls Say:

The Bulls Say summary highlights positive aspects of the stock.

Bears Say:

The Bears Say summary points out potential risks and negative aspects of the stock.

Show More
About XENE

Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.

Xenon Pharmaceuticals Inc (XENE) Historical Stock Prices

Xenon Pharmaceuticals Inc (XENE) closed at $36.56 on September 23, 2026. Over the past year its adjusted close ranged from $36.52 to $70.96. Daily prices go back to November 5, 2014, 2,987 trading days in all.

  • 1 month-39.63%
  • 3 months-34.22%
  • Year to date-18.43%
  • 1 year-2.01%
  • 3 years+3.95%
  • 5 years+142.60%
  • Max+248.19%
See every congressional and insider trade on the XENE price chart

Quiver Premium charts XENE's full daily history since 2014 with each congressional purchase and sale and every open-market insider purchase marked on the price line, with hover details for each trade.

Upgrade to Premium

Last 12 months, newest first

Access Raw Data Daily prices since 2014 for every ticker, through the Quiver API
DateOpenHighLowCloseAdj. CloseVolume
Sep 23, 2026 39.51 39.51 36.07 36.56 36.56 3,173,718
Sep 22, 2026 39.76 39.76 37.97 39.09 39.09 2,348,205
Sep 21, 2026 40.00 40.26 38.60 38.99 38.99 4,049,541
Sep 18, 2026 44.02 44.85 39.08 39.75 39.75 17,948,749
Sep 17, 2026 57.60 58.15 56.87 57.35 57.35 1,832,045
Sep 16, 2026 56.67 57.88 56.40 56.76 56.76 723,673
Sep 15, 2026 58.13 58.13 56.17 56.28 56.28 587,018
Sep 14, 2026 59.36 59.60 58.00 58.19 58.19 408,954
Sep 11, 2026 60.00 60.00 58.53 58.65 58.65 466,754
Sep 10, 2026 58.74 59.40 58.00 58.80 58.80 798,783
Sep 9, 2026 59.04 59.81 58.53 58.98 58.98 489,447
Sep 8, 2026 58.95 60.36 58.27 59.55 59.55 608,507
Sep 4, 2026 60.02 60.57 59.43 59.75 59.75 459,231
Sep 3, 2026 60.19 60.69 59.61 60.40 60.40 471,701
Sep 2, 2026 60.56 61.75 59.68 60.16 60.16 637,203
Sep 1, 2026 60.48 61.16 59.54 60.00 60.00 418,794
Aug 31, 2026 59.84 60.81 59.22 60.22 60.22 752,695
Aug 28, 2026 61.31 61.62 59.81 59.99 59.99 587,931
Aug 27, 2026 63.13 63.77 61.85 61.93 61.93 586,972
Aug 26, 2026 60.42 64.81 59.26 63.79 63.79 1,295,990
Aug 25, 2026 61.01 61.67 60.26 60.42 60.42 418,012
Aug 24, 2026 60.77 61.05 60.00 60.56 60.56 628,825
Aug 21, 2026 60.45 61.57 59.73 60.77 60.77 792,928
Aug 20, 2026 61.41 62.51 59.27 59.73 59.73 627,236
Aug 19, 2026 64.71 64.93 62.18 62.32 62.32 558,956
Aug 18, 2026 61.28 63.85 61.28 63.18 63.18 914,929
Aug 17, 2026 61.98 62.77 61.23 62.36 62.36 689,719
Aug 14, 2026 63.60 63.90 61.63 62.35 62.35 921,875
Aug 13, 2026 65.66 65.70 63.73 64.23 64.23 496,372
Aug 12, 2026 63.49 65.42 63.02 65.26 65.26 778,192
Aug 11, 2026 64.50 64.95 62.82 63.22 63.22 665,645
Aug 10, 2026 62.98 64.25 62.85 64.23 64.23 510,700
Aug 7, 2026 63.00 64.49 62.63 63.36 63.36 720,237
Aug 6, 2026 64.50 65.49 63.91 64.55 64.55 435,009
Aug 5, 2026 64.74 66.40 63.99 64.30 64.30 617,251
Aug 4, 2026 63.07 64.31 62.43 64.01 64.01 639,257
Aug 3, 2026 63.21 63.33 61.16 62.26 62.26 540,699
Jul 31, 2026 63.94 64.50 62.56 62.67 62.67 736,962
Jul 30, 2026 62.93 64.56 61.86 64.19 64.19 541,547
Jul 29, 2026 65.32 65.64 62.85 63.10 63.10 703,523
Jul 28, 2026 66.14 66.71 64.15 64.94 64.94 485,021
Jul 27, 2026 65.55 66.43 64.30 65.78 65.78 517,185
Jul 24, 2026 65.99 65.99 64.27 65.42 65.42 529,959
Jul 23, 2026 65.52 65.85 64.80 65.42 65.42 490,795
Jul 22, 2026 66.26 66.98 65.65 66.18 66.18 593,542
Jul 21, 2026 66.40 66.86 65.78 66.74 66.74 832,630
Jul 20, 2026 68.15 68.80 65.96 66.04 66.04 701,658
Jul 17, 2026 66.20 69.58 66.18 68.26 68.26 1,342,611
Jul 16, 2026 67.70 67.76 65.97 66.98 66.98 1,502,102
Jul 15, 2026 67.30 67.81 65.77 67.71 67.71 772,030
Jul 14, 2026 67.75 68.05 66.47 67.30 67.30 1,046,430
Jul 13, 2026 67.79 67.87 65.53 67.72 67.72 1,527,866
Jul 10, 2026 70.57 71.03 67.21 68.92 68.92 1,535,939
Jul 9, 2026 70.47 72.66 69.15 70.96 70.96 2,587,321
Jul 8, 2026 63.08 70.84 62.90 69.95 69.95 4,763,964
Jul 7, 2026 61.10 63.97 60.27 63.37 63.37 1,442,854
Jul 6, 2026 60.78 61.17 59.62 60.54 60.54 1,734,798
Jul 2, 2026 60.33 61.63 60.00 60.96 60.96 1,462,554
Jul 1, 2026 59.95 60.88 59.61 60.30 60.30 1,271,448
Jun 30, 2026 60.09 60.53 59.56 60.36 60.36 1,251,693
Jun 29, 2026 59.03 60.16 58.13 60.13 60.13 1,689,852
Jun 26, 2026 56.97 60.32 56.80 59.74 59.74 8,840,002
Jun 25, 2026 55.40 57.14 55.28 56.78 56.78 1,115,989
Jun 24, 2026 54.61 56.55 54.61 55.58 55.58 1,425,244
Jun 23, 2026 54.62 55.47 54.12 54.61 54.61 1,498,297
Jun 22, 2026 52.91 55.59 52.91 54.79 54.79 1,856,354
Jun 18, 2026 54.09 54.73 52.53 52.91 52.91 1,927,661
Jun 17, 2026 52.26 53.83 52.11 53.20 53.20 1,155,327
Jun 16, 2026 52.49 52.68 51.54 51.99 51.99 709,999
Jun 15, 2026 52.14 52.74 51.67 52.40 52.40 1,168,391
Jun 12, 2026 52.02 53.07 52.01 52.10 52.10 704,211
Jun 11, 2026 52.62 52.62 51.11 52.19 52.19 1,727,240
Jun 10, 2026 52.75 53.76 51.30 51.34 51.34 1,259,397
Jun 9, 2026 52.14 52.87 51.33 52.79 52.79 1,429,827
Jun 8, 2026 51.92 52.55 50.91 51.21 51.21 1,181,069
Jun 5, 2026 53.14 53.61 51.52 51.73 51.73 1,687,602
Jun 4, 2026 53.50 54.63 52.95 52.99 52.99 1,365,437
Jun 3, 2026 52.30 53.86 52.30 53.46 53.46 1,706,689
Jun 2, 2026 53.41 54.39 52.21 52.30 52.30 1,899,684
Jun 1, 2026 54.43 55.24 53.10 53.41 53.41 1,347,994
May 29, 2026 54.76 55.38 54.37 54.73 54.73 1,375,299
May 28, 2026 53.61 55.54 53.24 54.79 54.79 2,419,804
May 27, 2026 54.00 54.50 53.37 53.90 53.90 2,271,058
May 26, 2026 54.21 54.99 53.84 53.98 53.98 1,839,815
May 22, 2026 54.16 55.35 53.86 54.17 54.17 969,842
May 21, 2026 54.01 54.88 53.62 54.12 54.12 1,148,603
May 20, 2026 54.28 55.80 54.28 54.68 54.68 1,045,349
May 19, 2026 53.52 54.13 52.85 54.05 54.05 852,793
May 18, 2026 54.61 54.86 53.16 53.71 53.71 676,957
May 15, 2026 55.64 55.73 54.31 54.39 54.39 610,337
May 14, 2026 56.69 56.80 55.03 56.00 56.00 1,367,058
May 13, 2026 54.75 55.88 54.69 55.88 55.88 1,075,373
May 12, 2026 56.31 56.31 54.79 55.00 55.00 789,661
May 11, 2026 55.99 57.27 55.31 55.78 55.78 714,926
May 8, 2026 56.13 57.47 55.73 56.44 56.44 920,547
May 7, 2026 58.25 58.35 55.93 56.00 56.00 576,369
May 6, 2026 57.64 58.85 57.49 58.59 58.59 724,087
May 5, 2026 57.89 58.53 56.90 57.71 57.71 1,230,205
May 4, 2026 55.86 58.49 55.86 57.40 57.40 809,476
May 1, 2026 56.39 57.89 55.98 56.13 56.13 1,805,421
Apr 30, 2026 55.70 56.86 55.24 56.04 56.04 1,345,955
Apr 29, 2026 53.89 56.91 53.80 55.75 55.75 1,725,129
Apr 28, 2026 54.85 55.53 53.30 54.53 54.53 729,511
Apr 27, 2026 55.03 56.21 54.02 54.26 54.26 693,981
Apr 24, 2026 55.42 55.56 54.31 55.24 55.24 601,481
Apr 23, 2026 56.65 57.51 55.23 55.41 55.41 613,440
Apr 22, 2026 56.73 57.90 56.25 56.65 56.65 720,818
Apr 21, 2026 56.48 57.00 55.66 56.40 56.40 666,661
Apr 20, 2026 59.57 59.68 56.90 57.09 57.09 1,120,939
Apr 17, 2026 59.47 59.87 58.65 59.70 59.70 870,230
Apr 16, 2026 58.88 58.88 57.82 58.43 58.43 976,876
Apr 15, 2026 59.70 59.70 58.35 58.88 58.88 937,428
Apr 14, 2026 58.29 59.99 58.23 59.35 59.35 851,666
Apr 13, 2026 58.52 59.90 57.64 58.60 58.60 498,401
Apr 10, 2026 58.45 59.03 57.87 58.40 58.40 655,966
Apr 9, 2026 57.68 58.94 57.44 58.59 58.59 764,466
Apr 8, 2026 59.14 59.42 56.67 57.54 57.54 819,723
Apr 7, 2026 56.69 57.70 55.85 57.65 57.65 667,703
Apr 6, 2026 57.14 57.85 56.41 56.84 56.84 1,652,570
Apr 2, 2026 56.00 57.44 55.86 56.85 56.85 897,518
Apr 1, 2026 58.54 59.44 56.42 56.69 56.69 1,380,492
Mar 31, 2026 56.63 59.12 56.59 58.15 58.15 1,554,885
Mar 30, 2026 55.06 55.67 53.62 55.55 55.55 1,051,609
Mar 27, 2026 55.44 55.72 54.33 54.48 54.48 966,676
Mar 26, 2026 55.38 56.22 55.00 55.53 55.53 1,055,459
Mar 25, 2026 53.91 56.29 53.91 55.57 55.57 1,833,819
Mar 24, 2026 54.04 54.19 52.55 53.38 53.38 1,142,224
Mar 23, 2026 55.74 56.66 54.29 54.42 54.42 1,558,097
Mar 20, 2026 55.56 55.96 54.51 54.94 54.94 1,846,586
Mar 19, 2026 54.79 56.01 54.40 55.17 55.17 1,489,350
Mar 18, 2026 54.93 55.17 53.69 55.07 55.07 1,557,454
Mar 17, 2026 54.41 56.19 54.19 55.20 55.20 1,025,065
Mar 16, 2026 55.00 56.49 54.28 54.66 54.66 1,650,356
Mar 13, 2026 58.09 59.00 54.93 55.23 55.23 3,850,002
Mar 12, 2026 58.25 59.68 56.92 57.90 57.90 2,870,308
Mar 11, 2026 61.30 61.38 58.75 59.04 59.04 5,547,064
Mar 10, 2026 63.26 63.95 58.00 60.61 60.61 3,758,301
Mar 9, 2026 60.56 62.91 58.00 62.76 62.76 11,518,077
Mar 6, 2026 41.81 42.24 41.05 41.94 41.94 1,084,871
Mar 5, 2026 42.65 43.68 41.83 42.05 42.05 815,157
Mar 4, 2026 44.64 44.64 42.31 43.05 43.05 1,141,245
Mar 3, 2026 41.55 44.47 41.32 43.79 43.79 1,589,210
Mar 2, 2026 42.57 44.00 42.26 42.55 42.55 1,326,808
Feb 27, 2026 45.40 46.99 42.01 43.23 43.23 1,686,182
Feb 26, 2026 44.58 45.01 43.76 44.92 44.92 709,138
Feb 25, 2026 45.00 45.41 43.57 44.58 44.58 656,546
Feb 24, 2026 43.35 44.82 43.14 44.79 44.79 958,510
Feb 23, 2026 42.06 43.40 42.06 42.72 42.72 706,033
Feb 20, 2026 43.00 43.18 41.44 42.23 42.23 735,310
Feb 19, 2026 42.52 43.35 42.13 43.08 43.08 698,113
Feb 18, 2026 41.68 42.97 41.65 42.51 42.51 800,696
Feb 17, 2026 41.32 42.30 40.86 41.66 41.66 1,109,059
Feb 13, 2026 41.82 42.90 41.36 41.48 41.48 763,832
Feb 12, 2026 42.89 43.00 41.50 41.62 41.62 718,341
Feb 11, 2026 42.66 43.12 40.74 42.76 42.76 900,446
Feb 10, 2026 43.00 43.66 42.13 42.63 42.63 881,587
Feb 9, 2026 41.48 42.99 40.93 42.43 42.43 748,274
Feb 6, 2026 41.09 41.74 40.80 41.38 41.38 611,414
Feb 5, 2026 41.11 41.93 40.30 40.39 40.39 542,441
Feb 4, 2026 42.21 42.51 40.72 41.15 41.15 684,450
Feb 3, 2026 41.85 42.51 41.26 42.12 42.12 880,541
Feb 2, 2026 41.01 42.13 40.71 41.45 41.45 649,551
Jan 30, 2026 41.50 42.14 40.43 41.01 41.01 631,674
Jan 29, 2026 41.93 42.15 41.14 41.76 41.76 612,817
Jan 28, 2026 42.39 42.52 41.53 41.95 41.95 610,307
Jan 27, 2026 42.28 43.70 42.10 42.39 42.39 567,034
Jan 26, 2026 41.28 42.94 41.23 42.20 42.20 1,161,426
Jan 23, 2026 42.06 43.14 41.20 41.76 41.76 522,610
Jan 22, 2026 41.29 42.75 40.81 42.24 42.24 1,283,005
Jan 21, 2026 41.50 41.93 40.82 41.00 41.00 1,438,320
Jan 20, 2026 39.47 42.00 39.29 41.49 41.49 738,843
Jan 16, 2026 40.92 41.24 39.97 39.98 39.98 1,003,701
Jan 15, 2026 41.69 42.14 40.10 40.74 40.74 865,690
Jan 14, 2026 40.11 42.00 39.98 41.58 41.58 1,202,848
Jan 13, 2026 40.90 41.13 40.21 40.36 40.36 698,864
Jan 12, 2026 42.52 42.52 40.00 41.23 41.23 1,253,714
Jan 9, 2026 41.55 43.76 41.32 42.15 42.15 2,055,936
Jan 8, 2026 41.80 42.24 40.02 41.22 41.22 1,014,226
Jan 7, 2026 40.62 42.88 40.61 42.12 42.12 1,300,240
Jan 6, 2026 41.62 42.27 40.41 41.00 41.00 1,485,132
Jan 5, 2026 44.03 44.26 41.42 41.79 41.79 1,526,146
Jan 2, 2026 45.20 45.23 43.20 44.49 44.49 1,166,397
Dec 31, 2025 44.18 46.36 43.81 44.82 44.82 1,112,806
Dec 30, 2025 44.26 44.52 43.41 44.12 44.12 664,151
Dec 29, 2025 44.49 45.08 44.20 44.33 44.33 584,335
Dec 26, 2025 45.15 45.15 44.30 44.84 44.84 310,388
Dec 24, 2025 44.64 45.38 44.55 45.01 45.01 295,398
Dec 23, 2025 45.68 46.08 44.47 44.54 44.54 459,652
Dec 22, 2025 43.86 46.25 43.86 46.08 46.08 1,212,941
Dec 19, 2025 43.26 44.45 43.26 44.10 44.10 1,035,414
Dec 18, 2025 43.19 43.48 42.44 43.23 43.23 750,556
Dec 17, 2025 43.09 43.72 42.84 43.01 43.01 777,545
Dec 16, 2025 43.63 43.85 42.95 43.00 43.00 812,263
Dec 15, 2025 44.12 44.36 43.39 43.60 43.60 1,142,034
Dec 12, 2025 43.80 44.57 43.28 44.06 44.06 821,047
Dec 11, 2025 43.44 44.54 42.89 43.66 43.66 856,352
Dec 10, 2025 43.40 43.88 43.04 43.44 43.44 722,719
Dec 9, 2025 44.13 44.46 43.51 43.52 43.52 514,265
Dec 8, 2025 45.44 46.60 43.58 44.53 44.53 971,174
Dec 5, 2025 44.99 45.32 44.57 45.01 45.01 518,930
Dec 4, 2025 44.29 44.75 43.25 44.61 44.61 599,900
Dec 3, 2025 42.98 44.69 42.88 44.29 44.29 1,003,128
Dec 2, 2025 43.51 44.11 42.35 42.88 42.88 999,544
Dec 1, 2025 44.72 44.72 43.30 43.51 43.51 815,751
Nov 28, 2025 44.68 44.81 43.90 44.72 44.72 236,731
Nov 26, 2025 43.94 45.01 43.82 44.49 44.49 1,070,958
Nov 25, 2025 42.50 44.21 42.41 43.94 43.94 1,231,073
Nov 24, 2025 41.09 42.15 40.64 42.05 42.05 972,685
Nov 21, 2025 40.12 41.50 39.09 41.16 41.16 625,974
Nov 20, 2025 41.36 42.30 40.22 40.27 40.27 779,681
Nov 19, 2025 40.62 41.06 40.28 40.65 40.65 559,167
Nov 18, 2025 40.60 41.31 40.27 40.61 40.61 859,751
Nov 17, 2025 40.76 41.58 40.30 40.61 40.61 951,870
Nov 14, 2025 39.86 41.20 39.86 40.76 40.76 1,060,500
Nov 13, 2025 39.21 40.28 39.04 40.04 40.04 967,255
Nov 12, 2025 39.95 40.50 39.33 39.68 39.68 643,594
Nov 11, 2025 38.23 39.99 37.72 39.92 39.92 485,424
Nov 10, 2025 38.44 39.02 37.91 38.41 38.41 432,393
Nov 7, 2025 38.28 38.41 37.23 38.25 38.25 475,358
Nov 6, 2025 38.63 39.41 37.68 38.30 38.30 586,900
Nov 5, 2025 38.84 39.22 37.87 38.66 38.66 1,097,115
Nov 4, 2025 39.74 40.45 37.62 39.09 39.09 1,436,367
Nov 3, 2025 41.60 41.70 40.13 41.12 41.12 1,110,443
Oct 31, 2025 42.26 42.72 41.45 41.92 41.92 766,087
Oct 30, 2025 41.85 42.96 41.85 42.67 42.67 726,381
Oct 29, 2025 42.25 42.77 41.44 42.30 42.30 749,146
Oct 28, 2025 41.78 42.74 41.41 42.53 42.53 699,796
Oct 27, 2025 40.79 43.33 40.79 41.89 41.89 975,508
Oct 24, 2025 41.53 41.69 40.72 40.76 40.76 858,981
Oct 23, 2025 42.30 42.81 41.18 41.20 41.20 1,044,203
Oct 22, 2025 42.87 43.28 41.86 42.18 42.18 639,733
Oct 21, 2025 43.42 43.84 42.41 43.04 43.04 714,074
Oct 20, 2025 42.06 44.23 41.75 43.44 43.44 810,618
Oct 17, 2025 41.70 42.94 41.09 41.63 41.63 832,120
Oct 16, 2025 42.00 42.71 41.68 42.17 42.17 805,287
Oct 15, 2025 40.66 42.19 40.66 41.90 41.90 511,998
Oct 14, 2025 39.82 40.92 39.41 40.57 40.57 432,448
Oct 13, 2025 39.95 41.00 39.34 39.99 39.99 856,462
Oct 10, 2025 41.44 41.66 39.55 39.64 39.64 940,780
Oct 9, 2025 39.24 41.35 39.24 41.28 41.28 1,214,728
Oct 8, 2025 39.61 39.99 38.98 39.25 39.25 690,454
Oct 7, 2025 39.16 39.65 38.49 39.16 39.16 627,741
Oct 6, 2025 39.63 40.23 38.65 39.55 39.55 729,995
Oct 3, 2025 39.51 40.17 39.16 39.61 39.61 537,272
Oct 2, 2025 38.75 39.41 38.23 39.20 39.20 682,259
Oct 1, 2025 39.97 40.52 38.74 39.12 39.12 1,230,183
Sep 30, 2025 38.90 40.35 38.32 40.15 40.15 1,241,617
Sep 29, 2025 37.97 39.31 37.74 39.06 39.06 1,007,839
Sep 26, 2025 36.74 38.06 36.15 37.98 37.98 680,072
Sep 25, 2025 36.44 36.84 35.97 36.52 36.52 702,648
Sep 24, 2025 37.26 37.56 36.27 36.59 36.59 710,995
Sep 23, 2025 37.20 37.63 36.94 37.31 37.31 468,676

Open, high, low and close are the prices as traded. Adjusted close accounts for splits and dividends, and is what the chart and returns use. Where a company changed its ticker, its history under the old symbol is included.

Need daily prices for every ticker, in code?

The Quiver API serves daily prices back to 2014 alongside congressional trades, insider trades, 13F holdings and lobbying, all under one key and inside Claude or ChatGPT through our MCP server.

Explore the Quiver API
Xenon Pharmaceuticals Inc Executive Compensation

We estimate that -- received a compensation of -- in --, making them the highest paid executive at XENE, per a recent SEC DEF 14A filing. We estimate that the median employee at Xenon Pharmaceuticals Inc. is paid $269,373.



Name
Role
Salary
Bonus
Stock/Option Awards
Total Compensation